Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Wire Kansas.
November 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
December 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 |
January 2026
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on December 24, 2025
December 24, 2025
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Indeterminate
GlobeNewswire
December 24, 2025
Mondelēz Global LLC Conducts Voluntary Recall of 2 SKUs of CHIPS AHOY! Baked Bites Brookie in the US
Indeterminate
GlobeNewswire
December 24, 2025
Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support
Indeterminate
GlobeNewswire
December 24, 2025
Profound Medical Corp. Announces Upsize of Private Placement
Indeterminate
GlobeNewswire
December 24, 2025
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
Indeterminate
GlobeNewswire
December 24, 2025
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
Indeterminate
GlobeNewswire
December 24, 2025
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
Indeterminate
GlobeNewswire
December 24, 2025
Human Appeal launches e-greeting card collection to support emergency charity projects
Indeterminate
GlobeNewswire
December 24, 2025
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
Indeterminate
GlobeNewswire